Kronos Bio 

Quarterly Financials

Values in thousands 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Revenue
$2,370
$2,688
$2,520
$2,286
Gross Profit
2,370
2,268
1,248
1,808
EBITDA
-15,304
-17,025
-18,733
-24,842
EBIT
-15,716
-17,445
-20,005
-25,320
Net Income
-14,108
-16,200
-29,958
-25,320
Net Change In Cash
2,370
2,688
2,520
2,286
Free Cash Flow
-12,364
-16,329
-23,906
-25,055
Cash
74,964
70,207
46,197
64,325
Basic Shares
60,311
60,099
59,521
58,268

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$6,288
$3,084
$0
$0
Gross Profit
6,288
-4,463
-4,081
-4,866
EBITDA
-119,694
-134,849
-151,078
-79,688
EBIT
-121,830
-137,115
-151,314
-84,554
Net Income
-112,673
-129,293
-149,101
-64,087
Net Change In Cash
6,288
3,084
0
0
Cost of Revenue
-122,297
-49,740
217,466
Free Cash Flow
-79,261
-91,503
-122,184
-47,480
Cash
64,325
75,973
339,509
462,062
Basic Shares
57,744
56,201
54,753
54,073

Earnings Calls

Quarter EPS
2024-09-30
-$0.23
2024-06-30
-$0.27
2024-03-31
-$0.29
2023-12-31
-$0.43